Sabby Management’s Precigen PGEN Stock Holding History

Sabby Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-328	Closed	-$980K	–	343
2015 Q4	$980K	Hold	328	–	–	0.05%	188
2015 Q3	$1.03M	Buy	328 +1	+0.3%	+$49	0.04%	230
2015 Q2	$1.58M	Buy	+327	New	+$13.8K	0.06%	191
2015 Q1	–	Sell	-1,046	Closed	-$2.75K	–	319
2014 Q4	$2.75K	Hold	1,046	–	–	0.09%	102
2014 Q3	$1.86K	Buy	+1,046	New	+$21.4K	0.07%	115

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Sabby Management's PGEN Position: Q3 2016 in Review

Sabby Management sold out of Precigen (PGEN) in Q3 2016, closing a stake of 121,442 shares — an estimated $2.96M sold.

Sabby Management first reported a position in PGEN in Q3 2014 and held it in 4 quarters. The position peaked at $3.79M in Q1 2016. 168 funds tracked by Wall St. Rank hold PGEN as of Q3 2016.

Sabby Management reported no remaining Precigen position as of Q3 2016 after selling out during the quarter.
Sabby Management sold 121,442 Precigen shares in Q3 2016, an estimated $2.96M.
Sabby Management first reported a position in Precigen in Q3 2014 and held it in 4 quarters.
Sabby Management's Precigen position peaked at $3.79M in Q1 2016.
168 funds tracked by Wall St. Rank held Precigen as of Q3 2016.

Based on Sabby Management's 13F filing for Q3 2016, filed 14 Nov 2016.